Astellas Pharma Inc. - ADR
ALPMY
Market Cap$17.15B
Close$
$20.27
111.6% upside
Current Fair Value
111.6% upsideUndervalued by 111.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $17.15 Billion |
|---|---|
| Enterprise Value | $736.57 Billion |
| Dividend Yield | $0.16685 (5.30085959885387%) |
| Earnings per Share | $9.51 |
| Beta | 0.14 |
| Outstanding Shares | 1,795,749,761 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 49.25 |
|---|---|
| PEG | 364.66 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 0.43 |
| Enterprise Value to EBIT | 4.41 |
| Enterprise Value to Net Income | 42 |
| Total Debt to Enterprise | 1.39 |
| Debt to Equity | 0.61 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Astellas Pharma Inc.
CEO: Kenji Yasukawa